References
- Kovács G. Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy. J Contemp Brachytherapy 2014; 6: 404-16. doi: 10.5114/jcb.2014.47813
- Mazeron JJ, Ardiet JM, Haie-Méder C, Kovács G, Levendag P, Peiffert D, et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas Radiother Oncol 2009; 91: 150-6. doi: 10.1016/j. radonc.2009.01.005
- Takácsi-Nagy Z, Oberna F, Koltai P, Hitre, E, Major T, Fodor J, et al. Longterm outcomes with high-dose-rate brachytherapy for the management of base of tongue cancer. Brachytherapy 2013; 12: 535-41. doi: 10.1016/j. brachy.2013.07.001
- Major T, Polgár C, Mangel L, Takácsi-Nagy Z, Somogyi A, Németh G. CT based conformal brachytherapy treatment planning. Magy Onkol 2000; 44: 109-15. doi: HUON.2000.44.2.0109
- Yoshida K, Takenaka T, Akiyama H, Yamazaki H, Yoshida M, Masui K, et al. Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer. J Radiat Res 2014; 55: 154-61. doi: 10.1093/jrr/rrt079
- Akiyama H, Yoshida K, Yamazaki H, Takenaka T, Kotsuma, T, Masui, K, et al. High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial. J Contemp Brachytherapy 2014; 6: 10–4. doi: 10.5114/jcb.2014.40726
- Takácsi-Nagy Z, Martínez-Mongue R, Mazeron JJ, Anker CJ, Harrison LB. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies. Brachytherapy 2017; 16: 44-58. doi: 10.1016/j.brachy.2016.07.005
- Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial Radiother Oncol 2012; 104: 343-8. doi: 10.1016/j.radonc.2012.07.001
- Osborn J. Is VMAT beneficial for patients undergoing radiotherapy to the head and neck? Radiography 2017; 23: 73-6. doi: 10.1016/j.radi.2016.08.008
- Major T, Stelczer G, Pesznyák C, Mészáros N, Polgár C. Multicatheter interstitial brachytherapy versus intensity modulated external beam therapy for accelerated partial breast irradiation: A comparative treatment planning study with respect to dosimetry of organs at risk. Radiother Oncol 2017; 122: 17-23. doi: 10.1016/j.radonc.2016.08.003
- Sharma DN, Gandhi AK, Sharma S, Rath GK, Jagadesan P, Julka PK. Interstitial brachytherapy vs. intensity-modulated radiation therapy for patients with cervical carcinoma not suitable for intracavitary radiation therapy. Brachytherapy 2013; 12: 311-6. doi: 10.1016/j.brachy.2012.10.003
- Akiyama H, Major T, Polgár C, Takácsi-Nagy Z. Dose-volume analysis of target volume and critical structures in computed tomography image-based multi-catheter high-dose-rate interstitial brachytherapy for head and neck cancer. J Contemp Brachytherapy 2017; 9: 553-60. doi: 10.5114/jcb.2017.72581
- Major T, Polgár C. Treatment planning for multicatheter interstitial brachytherapy of breast cancer - from Paris system to anatomy-based inverse planning. J Contemp Brachytherapy 2017; 9: 89-98. doi: 10.5114/jcb.2017.66111
- Sresty NVNM, Ramanjappa T, Raju AK, Muralidhar KR, Sudarshan G. Acquisition of equal or better planning results with interstitial brachytherapy when compared with intensity-modulated radiotherapy in tongue cancers. Brachytherapy 2010; 9: 235-8. doi: 10.1016/j.brachy.2009.05.006
- Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, Van den Bogaert W. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 2004; 72: 119-27. doi: 10.1016/j.radonc.2004.03.014
- Chao KSC, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003; 55: 312-21.
- Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol 2011; 84: 967-96. doi: 10.1259/bjr/22373346
- Owosho AA, Tsai CJ, Lee RS, Freymiller H, Kadempour A, Varthis S, et al. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience. Oral Oncol 2017; 64: 44-51. doi: 10.1016/j.oraloncology.2016.11.015
- Stieler F, Wolff D, Schmid H, Welzel G, Wenz F, Lohr F. A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT. Radiother Oncol 2011; 101: 388-93. doi: 10.1016/j.radonc.2011.08.023
- Dawes C, Wood CM. The contribution of oral minor mucous gland secretions to the volume of whole saliva in man. Arch Oral Biol 1973; 18: 337-42.
- Sreebny LM. Saliva in health and disease: an appraisal and update. Int Dent J 2000; 50: 140-61.
- Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent 2001; 85: 162-9. doi: 10.1067/mpr.2001.113778
- Owosho AA, Thor M, Oh JH, Riaz, N, Tsai CJ, Rosenberg H, et al. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines. J Craniomaxillofac Surg 2017; 45: 595-600. doi: 10.1016/j.jcms.2017.01.020
- Eisbruch A, Rhodus N, Rosenthal D, Murphy B, Rasch C, Sonis S, et al. How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol 2003; 13: 226-34. doi: 10.1016/S1053-4296(03)00033-X
- Jellema AP, Doornaert P, Slotman BJ, Leemans CR, Langendijk JA. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy? Radiother Oncol 2005; 77: 164-71. doi: 10.1016/j. radonc.2005.10.002
- Dawes C. Rhythms in salivary flow rate and composition. Int J Chronobiol 1974; 2: 253-79.
- Wang ZH, Yan C, Zhang ZY, Zhang CP, Hu HS, Tu WY, et al. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study. Int J Radiat Oncol Biol Phys 2011; 81: 1479-87. doi: 10.1016/j.ijrobp.2010.07.1990
- Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 1995; 22: 209-34. doi: 10.1118/1.597458
- Peppa V, Pappas E, Major T, Takácsi-Nagy Z, Pantelis E, Papagiannis P. On the impact of improved dosimetric accuracy on head and neck high dose rate brachytherapy. Radiother Oncol 2016; 120: 92-7. doi: 10.1016/j. radonc.2016.01.022
- Nag S, Cano ER, Demanes DJ, Puthawala AA, Vikram B. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2001; 50: 1190-8.